Citigroup
C
Bank of America
BAC
Apple
AAPL
4
American Express
AXP
5
Chevron
CVX
US Stock MarketDetailed Quotes
ARCT Arcturus Therapeutics
- 18.050
- +1.640+9.99%
Close Feb 14 16:00 ET
- 18.000
- -0.050-0.28%
Post 20:01 ET
488.93MMarket Cap-7.75P/E (TTM)
18.885High16.500Low843.08KVolume16.500Open16.410Pre Close14.99MTurnover3.40%Turnover RatioLossP/E (Static)27.09MShares45.00052wk High1.87P/B447.66MFloat Cap14.30052wk Low--Dividend TTM24.80MShs Float129.710Historical High--Div YieldTTM14.53%Amplitude4.110Historical Low17.776Avg Price1Lot Size
Arcturus Therapeutics News
Arcturus Therapeutics Analyst Ratings
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
BTIG Initiates Arcturus Therapeutics(ARCT.US) With Buy Rating, Announces Target Price $41
Wells Fargo Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $58
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
Arcturus Therapeutics Analyst Ratings
Piper Sandler Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $140
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $74
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
Arcturus Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Madrigal Pharmaceuticals (MDGL)
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.
Arcturus Therapeutics Analyst Ratings
CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $74
H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63
Arcturus Therapeutics: Strong Buy Rating Backed by Promising Kostaive Sales and Promising Pipeline Developments
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now